Aclaris Therapeutics to Present at Upcoming Investor Conferences
November 12 2019 - 4:01PM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led
biopharmaceutical company focused on immuno-inflammatory diseases,
today announced that management will present at the following
conferences:
- Dr. Neal Walker, President and Chief Executive Officer,
together with members from the Company’s R&D team, will present
a company overview at SVB Leerink’s 13th Annual POLARxPRESS Bus
Tour in New York, New York on Thursday, November 21, 2019. The
R&D team will include:
- Joseph Monahan, Ph.D. - EVP R&D (Head of Discovery)
- Walter Smith - SVP, R&D
- Paul Changelian, Ph.D. - VP, Biology
- Jon Jacobsen, Ph.D. - VP, Chemistry
- Dr. David Gordon - Chief Medical Officer
- Dr. Walker will also present a company overview at the Evercore
ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019
at 3:05 PM ET at the Four Seasons Hotel in Boston, Massachusetts. A
live audio webcast of the presentation may be accessed through the
Company's web site, www.aclaristx.com, on the 'Events' section. An
archived version of the presentation will be available for 30
days.
About Aclaris Therapeutics, Inc.Aclaris
Therapeutics, Inc. is a physician-led biopharmaceutical company
committed to addressing the needs of patients with
immuno-inflammatory diseases who lack satisfactory treatment
options. The company’s diverse and multi-stage portfolio includes
one late-stage investigational drug candidate and a pipeline
powered by a robust R&D engine exploring protein kinase
regulation. For additional information, please visit
www.aclaristx.com and follow Aclaris on LinkedIn or Twitter
@aclaristx.
Aclaris ContactMichael Tung, M.D.Corporate Strategy/Investor
Relations484-329-2140mtung@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Sep 2023 to Sep 2024